Temozolomide and Unituxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temozolomide (temozolomide) and Unituxin (dinutuximab). Common drug interactions include bronchospasm among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Temozolomide and Unituxin. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Temozolomide?

Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 16,644 Temozolomide users. Check the latest studies of Temozolomide.

What is Unituxin?

Unituxin has active ingredients of dinutuximab. eHealthMe is studying from 489 Unituxin users. Check the latest studies of Unituxin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

41 people who take Temozolomide and Unituxin together, and have interactions are studied.

Temozolomide and Unituxin drug interactions.

What are the common drug interactions of Temozolomide and Unituxin, by gender? *:

female:

Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Hypersensitivity
Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Cardiac arrest
Cough
Death
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)

male:

Pyrexia (fever)
C-reactive protein increased
Neuroblastoma recurrent (reoccurrence of a cancer that forms in your nerve tissue)
Thrombocytopenia (decrease of platelets in blood)
Hypokalaemia (low potassium)
Nerve compression
Oxygen saturation decreased
Anaemia (lack of blood)
Fatigue (feeling of tiredness)
Leukocytosis (increased white blood cells)

What are the common drug interactions of Temozolomide and Unituxin, by age (0-1 to 60+)? *:

0-1:

Anaphylactic reaction (serious allergic reaction)

2-9:

Thrombocytopenia (decrease of platelets in blood)
Antibody test positive
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Anaphylactic reaction (serious allergic reaction)
Pneumonia
Pyrexia (fever)
Hallucination (an experience involving the perception of something not present)
Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

10-19:

Cardiac arrest
Death
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Lethargy (tiredness)
Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
Metastatic neoplasm (spreadable cancer tumour)
Neuroblastoma (a cancer that forms in your nerve tissue)

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain upper
Asthenia (weakness)
Hypoaesthesia (reduced sense of touch or sensation)
Hypotension (abnormally low blood pressure)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)
Neuralgia (pain in one or more nerves)
Neuroblastoma (a cancer that forms in your nerve tissue)
Pain in extremity
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Neuroblastoma (a cancer that forms in your nerve tissue): 20 people, 48.78%
Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 11 people, 26.83%
Pain: 5 people, 12.20%
Metastases To Bone (cancer spreads to bone): 4 people, 9.76%
Stress And Anxiety: 3 people, 7.32%
Neoplasm Progression (growth of tumour): 3 people, 7.32%
Metastases To Liver (cancer spreads to liver): 3 people, 7.32%
Itching: 3 people, 7.32%
Gastric Disorder (disease of stomach): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Temozolomide and Unituxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously